• Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘Samuel Isaly OrbiMed Advisors’

Philip Hempleman, Ardsley Partners Initiate Position in Supernus Pharmaceuticals Inc (SUPN)

Philip Hempleman has become a fan of Supernus Pharmaceuticals Inc (NASDAQ:SUPN).

Keep Reading →

December 13 - Hedge Funds, News - Comments

Goldman Capital Management Reduces Stake in Bacterin International Holdings Inc (BONE)

Goldman Capital Management Inc has reduced its exposure to Bacterin International Holdings Inc (NYSEMKT:BONE).

Keep Reading →

December 12 - Hedge Funds, News - Comments

Sam Isaly, Orbimed Now Hold 53.3% of Response Biomedical

Sam Isaly's Orbimed Advisors focuses on healthcare investments, and it has now disclosed a change to its holdings of Response Biomedical Corp.

Keep Reading →

November 12 - Hedge Funds, News - Comments

The Biggest Biogen Idec Inc. (BIIB) Bulls Around

In the financial blogosphere, there are a lot of analytical tools for Biogen Idec Inc.

Keep Reading →

August 31 - News - Comments

Pfizer Inc. (PFE), Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK) Among Hedge Funds’ Favorite Pharma Stocks

We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors.

Keep Reading →

August 27 - Hedge Funds - Comments

Should You Buy Vocera Communications Inc (VCRA)?

Vocera Communications Inc (NYSE:VCRA) was in 14 hedge funds' portfolio at the end of the first quarter of 2013.

Keep Reading →

June 14 - News - Comments

Is Given Imaging Ltd. (GIVN) Going to Burn These Hedge Funds?

Given Imaging Ltd. (NASDAQ:GIVN) was in 14 hedge funds' portfolio at the end of March. GIVN has seen an increase in enthusiasm from smart money lately.

Keep Reading →

June 13 - News - Comments

Is Array Biopharma Inc (ARRY) Going to Burn These Hedge Funds?

If you'd ask most shareholders, hedge funds are seen as slow, old investment vehicles of the past.

Keep Reading →

June 10 - News - Comments

Is Acorda Therapeutics Inc (ACOR) Going to Burn These Hedge Funds?

Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of March. ACOR has experienced a decrease in hedge fund sentiment lately.

Keep Reading →

June 8 - News - Comments

Impax Laboratories Inc (IPXL): Insiders Are Buying, Should You?

In the financial world, there are plenty of metrics market participants can use to track publicly traded companies.

Keep Reading →

June 4 - News - Comments

Regeneron Pharmaceuticals Inc (REGN): Are Hedge Funds Right About This Stock?

To the average investor, there are dozens of indicators market participants can use to analyze the equity markets.

Keep Reading →

June 3 - News - Comments

Orbimed Advisors Takes a Major Stake in Ambit Biosciences Corp (AMBI)

In the smart money’s world, Samuel Isaly’s Orbimed Advisors reported a purchase of some 2.1 million shares of Ambit Biosciences Corp (NASDAQ:AMBI) in a 13D filing with the...

Keep Reading →

May 31 - Hedge Funds, News - Comments

Hedge Funds Are Betting On Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) was in 63 hedge funds' portfolio at the end of March. GILD shareholders have witnessed an increase in hedge fund sentiment of late.

Keep Reading →

May 30 - News - Comments

Here is What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds' portfolio at the end of March.

Keep Reading →

May 30 - News - Comments

Is Biogen Idec Inc. (BIIB) Going to Burn These Hedge Funds?

To most traders, hedge funds are assumed to be worthless, outdated financial tools of years past.

Keep Reading →

May 28 - News - Comments

Amgen, Inc. (AMGN): Insiders Aren’t Crazy About It

Amgen, Inc. (NASDAQ:AMGN) was in 36 hedge funds' portfolio at the end of the first quarter of 2013.

Keep Reading →

May 28 - News - Comments

Hedge Fund News: Warren Buffett, Steve Cohen, Sprint Nextel Corporation (S)

Editor's Note: Related Tickers: Baidu.com, Inc. (ADR) (NASDAQ:BIDU), Micron Technology, Inc.

Keep Reading →

April 18 - News - Comments

Infinity Pharmaceuticals Inc. (INFI): Billionaire Steve Cohen’ SAC Up to 5% of This Stock

According to a 13G filed with the SEC, SAC Capital Advisors, a hedge fund managed by billionaire Steve Cohen, owned 2.4 million shares of Infinity Pharmaceuticals Inc.

Keep Reading →

April 17 - Hedge Funds - Comments

Here is What Hedge Funds Think About Antares Pharma Inc (ATRS)

In the 21st century investor’s toolkit, there are a multitude of metrics shareholders can use to track the equity markets.

Keep Reading →

April 16 - News - Comments

Hedge Funds Are Selling XOMA Corp (XOMA)

If you'd ask most investors, hedge funds are perceived as slow, outdated financial tools of the past.

Keep Reading →

April 15 - News - Comments

This Metric Says You Are Smart to Sell Endocyte, Inc. (ECYT)

In the financial world, there are tons of indicators investors can use to monitor publicly traded companies. A couple of the best are hedge fund and insider trading interest.

Keep Reading →

April 15 - News - Comments

Hedge Funds Aren’t Crazy About Fluidigm Corporation (FLDM) Anymore

Fluidigm Corporation (NASDAQ:FLDM) was in 7 hedge funds' portfolio at the end of the fourth quarter of 2012.

Keep Reading →

April 15 - News - Comments

Hedge Funds Are Buying Uroplasty, Inc. (UPI)

Is Uroplasty, Inc. (NASDAQ:UPI) an excellent investment now? The smart money is taking an optimistic view.

Keep Reading →

April 12 - News - Comments

Given Imaging Ltd. (GIVN): Hedge Funds and Insiders Are Bearish, What Should You Do?: Cynosure, Inc. (CYNO), Symmetry Medical Inc. (SMA)

Given Imaging Ltd. (NASDAQ:GIVN) was in 9 hedge funds' portfolio at the end of December.

Keep Reading →

April 6 - News - Comments

Hedge Funds Are Dumping Dendreon Corporation (DNDN): Achillion Pharmaceuticals, Inc. (ACHN), TESARO Inc (TSRO)

If you'd ask most traders, hedge funds are perceived as underperforming, outdated investment tools of years past.

Keep Reading →

April 5 - News - Comments

Medivation Inc (MDVN), Amarin Corporation plc (ADR) (AMRN), Abbott Laboratories (ABT): Adage Capital Management Owns 5.4% of This Company

According to a 13G filed with the SEC, Adage Capital Management, a large hedge fund managed by Phil Gross and Robert Atchinson, owns just over 4 million shares of Medivation Inc...

Keep Reading →

April 4 - Hedge Funds - Comments

Hedge Funds Aren’t Crazy About MAKO Surgical Corp. (MAKO) Anymore: The Spectranetics Corporation (SPNC), Symmetry Medical Inc. (SMA)

MAKO Surgical Corp. (NASDAQ:MAKO) was in 13 hedge funds' portfolio at the end of December. MAKO investors should pay attention to a decrease in hedge fund interest lately.

Keep Reading →

April 3 - News - Comments

XenoPort, Inc. (NASDAQ:XNPT): Insiders Are Dumping, Should You?: Obagi Medical Products, Inc. (OMPI), Vical Incorporated (VICL)

XenoPort, Inc. (NASDAQ:XNPT) was in 13 hedge funds' portfolio at the end of December.

Keep Reading →

April 3 - News - Comments

Hedge Funds Aren’t Crazy About Neurocrine Biosciences, Inc. (NBIX) Anymore: Keryx Biopharmaceuticals (KERX), Rigel Pharmaceuticals, Inc. (RIGL)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 12 hedge funds' portfolio at the end of December.

Keep Reading →

April 3 - News - Comments

Hedge Funds Are Betting On Natus Medical Inc (NASDAQ:BABY) – GenMark Diagnostics, Inc (NASDAQ:GNMK), Symmetry Medical Inc. (NYSE:SMA)

Natus Medical Inc (NASDAQ:BABY) was in 15 hedge funds' portfolio at the end of December. BABY investors should pay attention to an increase in hedge fund interest recently.

Keep Reading →

April 2 - News - Comments

Should You Buy Impax Laboratories Inc (NASDAQ:IPXL)?

If you'd ask most shareholders, hedge funds are seen as slow, outdated financial vehicles of yesteryear.

Keep Reading →

April 2 - News - Comments

Hedge Funds Are Crazy About Sequenom, Inc. (NASDAQ:SQNM)

Sequenom, Inc. (NASDAQ:SQNM) was in 15 hedge funds' portfolio at the end of December. SQNM shareholders have witnessed an increase in hedge fund sentiment lately.

Keep Reading →

March 29 - News - Comments

Here is What Hedge Funds Think About OraSure Technologies, Inc. (NASDAQ:OSUR)

In the 21st century investor’s toolkit, there are a multitude of indicators shareholders can use to monitor the equity markets.

Keep Reading →

March 28 - News - Comments

Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Are Hedge Funds Right About This Stock?

In the financial world, there are many methods shareholders can use to analyze the equity markets.

Keep Reading →

March 27 - News - Comments

Do Hedge Funds and Insiders Love Warner Chilcott Plc (NASDAQ:WCRX)?

At the moment, there are a multitude of metrics market participants can use to monitor publicly traded companies.

Keep Reading →

March 25 - News - Comments

Should You Buy Life Technologies Corp. (NASDAQ:LIFE)?

In today’s marketplace, there are many methods shareholders can use to analyze the equity markets. A duo of the most underrated are hedge fund and insider trading interest.

Keep Reading →

March 21 - News - Comments

A Board Member Bought Over $300,000 of Abbott Labs

A member of Abbott Laboratories (NYSE:ABT)’s Board of Directors, William Osborn, recently bought 10,000 shares of stock at prices between $33.80 and $33.90.

Keep Reading →

February 5 - Insider Trading - Comments

Healthcare Investor Sam Isaly’s Top Stock Picks Include Pfizer

Sam Isaly’s Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets.

Keep Reading →

January 8 - Hedge Funds - Comments

Billionaire Ken Fisher Thinks Pfizer Is Right For You

Billionaire Ken Fisher isn’t only the head of Fisher Asset Management, but also a long-running Forbes columnist whose picks published in that magazine have tended to outperform...

Keep Reading →

November 27 - Hedge Funds - Comments

Is Bristol Myers Squibb a Good Stock to Buy?

Bristol Myers Squibb Co.

Keep Reading →

October 15 - Stock Analysis - Comments

Orbimed Still Selling Pacira

Between April and June of this year, Orbimed Advisors sold 18% of its shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX), finishing the second quarter with exactly 2 million shares...

Keep Reading →

October 1 - Hedge Funds - Comments

Why is Orbimed Backing Out of Amarin?

Orbimed Advisors, managed by Samuel Isaly, is a hedge fund with a focus on the healthcare sector.

Keep Reading →

September 8 - Hedge Funds - Comments

Peter Kolchinsky’s RA Capital Management Raised Stake In Endocyte $ECYT

Peter Kolchinsky’s RA Capital Management reported 7.32% passive stake in Endocyte Inc. (ECYT).

Keep Reading →

December 27 - Hedge Funds - Comments

Samuel Isaly Reported Changes in His Third Quarter Holdings

Samuel Isaly reported his amended 13F portfolio on November 23rd. He made a lot of changes to his original third quarter 13F which was filed a few days ago.

Keep Reading →

November 29 - Hedge Funds - Comments

Insider Trading: Samuel Isaly’s Orbimed Advisors is Selling $ANTH

Samuel Isaly’s Orbimed Advisors filed for its recent insider sales in Anthera Pharmaceuticals Inc (ANTH) on November 18th.

Keep Reading →

November 22 - Hedge Funds, Insider Trading - Comments

Hedge Funds Make Big After Regeneron $REGN Gets FDA OK for Eylea

Regeneron Pharmaceuticals Inc.'s (REGN) shares rose 13.73% in trading on Monday after U.S.

Keep Reading →

November 21 - Hedge Funds, Market Movers - Comments

Hedge Funds Make a Bundle on Inhibitex $INHX

Shares of Inhibitex (INHX) more than doubled Friday morning.

Keep Reading →

November 4 - Hedge Funds - Comments

Hedge Funds Make Big on Humana $HUM

Humana Inc (HUM) swelled from $80.24 a share at open on Monday to hit anew 52-week high of $87.32 a share after it "announced earnings of $444.8 million, or $2.67 a share, up ...

Keep Reading →

October 31 - Hedge Funds - Comments

Insider Trading: Daniel Gold’s QVT Financial Sold 650 Thousand Shares in $ANDS

Daniel Gold’s QVT Financial sold 650 thousand shares in Anadys Pharmaceuticals Inc. (ANDS) on October 17th. According to the firm’s Form 4 and amend 13D on October 19th.

Keep Reading →

October 20 - Hedge Funds, Insider Trading - Comments

Hedge Funds Make a Bundle on Edwards Lifesciences $EW Increase

Edwards Lifesciences Corp (EW) "third-quarter earnings rose 7.5% on a tax benefit as the heart-valve maker's investments in its expected Sapien launch hurt margins, despite sales...

Keep Reading →

October 20 - Hedge Funds - Comments

« Older Entries
Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$293,447,417,000

David Einhorn

David Einhorn

Greenlight Capital

$1,491,303,000

George Soros

George Soros

Soros Fund Management

$5,416,602,000

Jim Simons

Jim Simons

Renaissance Technologies

$77,426,184,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$1,886,381,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$22,521,664,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$22,767,998,000

John Paulson

John Paulson

Paulson & Co

$3,510,256,000

David Tepper

David Tepper

Appaloosa Management LP

$4,198,712,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$6,160,740,000

Insider Monkey Small Cap Strategy
JulJanJulJanJulJanJulJan0%50%100%150%Return %Monthly Newsletter StrategyS&P 500
Most Read Posts
Dump Your Hedge Funds and Buy This Stock
World’s Most Expensive Desserts
The 10 Best Selling Products Online
The 10 Best Selling Items on Etsy
The 12 Most Profitable Small Businesses
The 10 Best-Selling Video Games of All Time
Lists

10 Biggest Online Streaming Companies in the World

10 Biggest Online Streaming Companies in the World

15 Most Valuable E-Commerce Companies in the World

15 Most Valuable E-Commerce Companies in the World

15 Most Valuable Software Companies in the World

15 Most Valuable Software Companies in the World

15 Most Valuable Platform Companies in the World

15 Most Valuable Platform Companies in the World

10 Biggest Crypto Companies in the World

10 Biggest Crypto Companies in the World

11 Best Augmented Reality Stocks to Invest In

11 Best Augmented Reality Stocks to Invest In

10 Best Plant Based Companies to Invest In

10 Best Plant Based Companies to Invest In

10 Best Tech Stocks to Buy For The Long Term

10 Best Tech Stocks to Buy For The Long Term

Naval Ravikant’s Latest Investment Portfolio: 10 Companies to Watch

Naval Ravikant’s Latest Investment Portfolio: 10 Companies to Watch

13 Most Ambitious Metaverse Companies in the World

13 Most Ambitious Metaverse Companies in the World

10 Most Profitable Biotech Companies in the World

10 Most Profitable Biotech Companies in the World

5 Most Profitable Biotech Companies in the World

5 Most Profitable Biotech Companies in the World

10 Cryptocurrencies Millionaires Love

10 Cryptocurrencies Millionaires Love

5 Largest Chip Producers In The World

5 Largest Chip Producers In The World

12 Largest Chip Producers In The World

12 Largest Chip Producers In The World

12 Biggest Agriculture Companies in the World

12 Biggest Agriculture Companies in the World

10 Cryptocurrencies To Buy and Hold for the Next 10 Years

10 Cryptocurrencies To Buy and Hold for the Next 10 Years

5 Biggest Green Energy Companies in the World

5 Biggest Green Energy Companies in the World

15 Most Valuable Real Estate Companies in the World

15 Most Valuable Real Estate Companies in the World

15 Most Valuable Korean Companies in the World

15 Most Valuable Korean Companies in the World

15 Most Valuable UK Companies in the World

15 Most Valuable UK Companies in the World

15 Most Valuable Japanese Companies in the World

15 Most Valuable Japanese Companies in the World

15 Most Valuable Beer Companies in the World

15 Most Valuable Beer Companies in the World

15 Most Valuable German Companies

15 Most Valuable German Companies

5 Most Valuable German Companies

5 Most Valuable German Companies

15 Most Valuable Government-Owned Companies in the World

15 Most Valuable Government-Owned Companies in the World

5 Most Valuable Government-Owned Companies in the World

5 Most Valuable Government-Owned Companies in the World

10 3D Printing Companies to Watch in 2022

10 3D Printing Companies to Watch in 2022

25 Safest Countries in the World

25 Safest Countries in the World

5 Safest Countries in the World

5 Safest Countries in the World

25 Most Aggressive Dog Breeds in America

25 Most Aggressive Dog Breeds in America

25 Most Popular Dog Breeds in the World

25 Most Popular Dog Breeds in the World

50 Things to Do When Bored

50 Things to Do When Bored

15 Most Valuable New Zealand Companies in the World

15 Most Valuable New Zealand Companies in the World

Top 15 Most Valuable Italian Companies

Top 15 Most Valuable Italian Companies

Top 22 Packaging Companies in USA

Top 22 Packaging Companies in USA

25 Best Countries in the World

25 Best Countries in the World

30 Easy Things to Draw When You are Bored

30 Easy Things to Draw When You are Bored

15 Most Valuable Space Companies in the World

15 Most Valuable Space Companies in the World

15 Most Valuable Cigarette Companies in the World

15 Most Valuable Cigarette Companies in the World

10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors

10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors

15 Most Valuable Data Companies in the World

15 Most Valuable Data Companies in the World

15 Most Anticipated Movies of 2021 and 2022

15 Most Anticipated Movies of 2021 and 2022

21 Best Android Phones to Buy for 2021

21 Best Android Phones to Buy for 2021

15 Most Valuable South African Companies

15 Most Valuable South African Companies

15 Cheapest New Cars for 2021

15 Cheapest New Cars for 2021

25 Most Expensive Cars in the World

25 Most Expensive Cars in the World

30 Most Valuable Publicly Traded Defense Companies In The World

30 Most Valuable Publicly Traded Defense Companies In The World

15 Affordable Liberal Cities in America

15 Affordable Liberal Cities in America

15 Fastest Growing Fast Food Chains

15 Fastest Growing Fast Food Chains
Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse
Home Hedge Funds Markets Blog Site Map
Authors About Us Contact Us Privacy Policy Terms of Use CCPA - Do Not Sell My Information
All text and design is copyright ©2021 Koala Guide LLC. All rights reserved.